Journals in Cardiovascular pharmacology

2 results in All results

European Journal of Pharmacology

• ISSN: 0014-2999
• 5 Year impact factor: 4.3
• Impact factor: 4.2

The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems.The scope includes: Behavioural pharmacology, Neuropharmacology and psychopharmacology, Cardiovascular pharmacology, Pulmonary, gastrointestinal and urogenital pharmacology, Endocrine pharmacology, Immunopharmacology and inflammation, Molecular and cellular pharmacology, Regenerative pharmacology, Biologicals and biotherapeutics, Translational pharmacology and Nutriceutical pharmacology.The journal publishes full-length papers and reviews. Ethnopharmacological studies with plant extracts or mixtures are not in scope of this journal.The table of contents for this journal is now available pre-publication, via e-mail, as part of the free ContentsDirect service from Elsevier. Please send an e-mail message to [email protected] for further information about this service.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscribe

Vascular Pharmacology

• ISSN: 1537-1891
• 5 Year impact factor: 4.1
• Impact factor: 3.5

Vascular Pharmacology is a journal of Vascular Biology and Medicine. We seek to rapidly publish transformative papers, reviews, and perspectives on vascular cells across the disciplines of biochemistry, pharmacology, pathology, physiology, molecular and developmental biology, and clinical medicine using sophisticated tools in genomics/proteomics/transcriptomics, genetics, genome editing, and bioengineering.The journal will consider submissions that address vascular cells in the context of:Atherosclerosis, thrombosis, hemostasisNeurovascular diseasesDiabetes, obesity, and metabolic syndromePulmonary hypertensionCardiovascular toxicity induced by anticancer drugsTransplant arteriopathyVascular aging, repair, and regenerationReperfusion injuryImmunological influence in vascular diseasesMicrovascular dysfunctionPlease check the latest journal related topics and articles on our Twitter account @VasPharma.

Subscribe